Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders
Summary of Botuo Biotech\'s 2024 Semi-Annual Report
Botuo Biotech\'s announcement on holding the 2024 semi-annual results briefing
Verification opinions of Guotai Junan Securities Co., Ltd. on the termination of part of the initial public offering of shares of Hangzhou Botuo Biotechnology Co., Ltd. and investing the remaining funds raised in new projects, permanently replenish working capital, and continue to store them in special fund-raising accounts
Botuo Biotech\'s announcement on the termination of some fund-raising projects and investing the remaining funds in new projects, permanently replenishing working capital, and continuing to store them in special fund-raising accounts
Verification opinion of Guotai Junan Securities Co., Ltd. on the use of its own funds by Hangzhou Botuo Biotechnology Co., Ltd. to pay the funds required for the fund-raising project and replace them in equal amounts with the funds raised
Botuo Biotech\'s announcement on using its own funds to pay the funds required for fund-raising projects and replacing them in equal amounts with the raised funds
Guotai Junan Securities Co., Ltd.\'s inspection opinion on the initial public offering of some restricted shares of Hangzhou Botuo Biotechnology Co., Ltd.
Botuo Biotech\'s initial public offering of some restricted shares
Special report on the storage and actual use of funds raised by Botuo Biotech for the 2024 semi-year
Botuo Biotech\'s Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Opinions of Guotai Junan Securities Co., Ltd. on the verification of the use of some temporarily idle funds raised by Hangzhou Botuo Biotechnology Co., Ltd. for cash management
Botuo Biotech\'s Announcement on Using Some Temporarily Idle Raised Funds for Cash Management
Announcement of Resolutions of the 11th Meeting of the 3rd Board of Supervisors of Botuo Biotech
Guotai Junan Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Hangzhou Botuo Biotechnology Co., Ltd.
Botuo Biotech 2024 Semi-Annual Report
Announcement of the results of BoTai Biology's repurchase of company shares through centralized bidding trading, reaching 2% of the total share capital.
Announcement on the progress of Botai Biotechnology's repurchase of company shares by means of centralized bidding trade.
Announcement regarding the adjustment of the repurchase share price limit after the implementation of the annual equity distribution of Biotop in 2023.
Botuo Biotech's 2023 Annual Equity Distribution Implementation Notice
No Data